Loading…
Lobbying Spend
—
Filings
36
Firms Hired
1
Active Period
2018–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1038
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1038
Prescription Transparency Act of 2018
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Prescription Transparency Act of 2018
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6157
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6157
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6470
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6470
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6733
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6733
Know the Lowest Price Act of 2018
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 2553
Know the Lowest Price Act of 2018
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 2553
Patient Right to Know Drug Prices Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 2554
Patient Right to Know Drug Prices Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 2554
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 413
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · fourth_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: S. 413
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1038
Improving Transparency and Accuracy in Medicare Part D Spending Act
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 1038
Prescription Transparency Act of 2018
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Prescription Transparency Act of 2018
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 5343
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6157
Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6157
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6470
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2019
2018 · third_quarter · Firm: CSS PARTNERS, LLC
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6470
Legislation H.R. 5343 - Prescription Transparency Act of 2018. (Lobbying activities related to pharmacy benefit managers.) H.R. 6470 - Making appropriations for the Departments of Labor, Health and Human Services, and Education, and related agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) H.R. 6157 - Making consolidated appropriations for the Departments of Defense, Labor, Health and Human Services, and Education, and Related Agencies for the fiscal year ending September 30, 2019, and for other purposes. (Lobbying activities related to DIR fees.) S. 413 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) H.R. 1038 - To amend title XVIII of the Social Security Act to prohibit prescription drug plan sponsors and MA-PD organizations under the Medicare program from retroactively reducing payment on clean claims submitted by pharmacies. (Lobbying activities related to pharmacy benefit managers.) S. 2553 - To amend title XVIII of the Social Security Act to prohibit health plans and pharmacy benefit managers from restricting pharmacies from informing individuals regarding the prices for certain drugs and biologicals. (Lobbying activities related to pharmacy benefit managers.) S. 2554 - To ensure that health insurance issuers and group health plans do not prohibit pharmacy providers from providing certain information to enrollees. (Lobbying activities related to pharmacy benefit managers.) H.R. 6733 - To amend title XXVII of the Public Health Service Act and title XVIII of the Social Security Act to prohibit group health plans, health insurance issuers, prescription drug plan sponsors, and Medicare Advantage organizations from limiting certain information on drug prices. (Lobbying activities related to pharmacy benefit managers.) Issues Prescription drug prices Pharmacy benefit managers DIR Fees
Client expense: — · Firm income: $20,000
Matched citations: H.R. 6733
Source: Senate LDA